NCT04411901View on ClinicalTrials.gov

The Role of Vitamin D3 in Pediatric Bronchiectasis Severity

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 6, 2018

Study Completion Date

March 20, 2019

Conditions
Cystic Fibrosis and Non CF Bronchiectasis
Interventions
DRUG

Cholecalciferol (vitaminD3)

Theraputic vitamin D3 for CF and non CF bronchiectasis children

Trial Locations (1)

02

Children hospital, Cairo

All Listed Sponsors
lead

Heba Omara

OTHER

NCT04411901 - The Role of Vitamin D3 in Pediatric Bronchiectasis Severity | Biotech Hunter | Biotech Hunter